Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?

Both acute and advanced heart failure are an increasing threat in term of survival, quality of life and socio-economical burdens. Paradoxically, the use of successful treatments for chronic heart failure can prolong life but—per definition—causes the rise in age of patients experiencing acute decomp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollesello, Piero, Ben Gal, Tuvia, Bettex, Dominique, Cerny, Vladimir, Comin-Colet, Josep, Eremenko, Alexandr A., Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Harjola, Veli-Pekka, Herpain, Antoine, Heringlake, Matthias, Heunks, Leo, Husebye, Trygve, Ivancan, Visnja, Karason, Kristjan, Kaul, Sundeep, Kubica, Jacek, Mebazaa, Alexandre, Mølgaard, Henning, Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Vrtovec, Bojan, Yilmaz, Mehmet B., Papp, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912236/
https://www.ncbi.nlm.nih.gov/pubmed/31683969
http://dx.doi.org/10.3390/jcm8111834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912236/
https://www.ncbi.nlm.nih.gov/pubmed/31683969
http://dx.doi.org/10.3390/jcm8111834

Ejemplares similares